The Endocrine Society is pleased to offer an inaugural blended learning experience on best practices in obesity care, exclusively for endocrinology fellows.

Chaired by renowned obesity medicine expert Amy Rothberg, MD, DABOM, the Obesity Fellows program is an exclusive, application-based educational activity for current fellows, offering several modes of learning:

  • Engaging, in-person program in downtown Washington, D.C. October 20-21, where fellows get the opportunity to meet with the top experts in the field of obesity care and management;
  • 6 on-demand lectures with related pre- and post-test questions, covering foundational topics on obesity clinical practice; and
  • Complementary Endocrine News podcast episode

The program accepts up to 35 US-domestic fellows for full participation in the in-person program. The on-demand lectures and podcast will then be available to everyone following the in-person workshop.


Travel, 2-night hotel accommodation, and meal expenses will be covered by the Endocrine Society.


The 2023 Obesity Fellows Program has concluded. Stay tuned for the on-demand course available later this year!

2023 Program Outline

In-Person Program Agenda 


Friday, October 20:

  • Dinner and Evening Keynote: Summarizing the Current State of Obesity Management

Saturday, October 21:

  • Panel Discussion: Players, Characteristics and Roles of an Effective Obesity Team
  • Patient-First Strategies: When & How to Discuss Weight & Factors Affecting Weight Loss and Weight Control
  • The Good, The Bad, & The Ugly of Mobile Apps in Weight Management
  • Anti-Obesity Drugs: Where Are We Now and Where Do We Need to Go?
  • Challenging Cases: Managing Polypharmacy & Comorbidities
  • Challenging Cases: Acute & Long-Term Considerations in Weight-Loss Surgery

On-Demand Lectures

  • Overview: Current Prevalence of Obesity and Definition as a Chronic Disease
  • Genetic & Environmental Pathophysiology of Obesity
  • Lifestyle Assessment, Intervention, & Monitoring in Obesity
  • Pharmaceutical Options I ~ Past, Current, and Future Options
  • Pharmaceutical Options II ~ Recommendations & Clinical Inertia
  • Updates on Surgical and Procedural Interventions for Obesity

Meet the Faculty

Amy Rothberg, MD (Chair)

University of Michigan


Disclosures: None

Jaime Almandoz, MD

UT Southwestern Medical Center


Disclosures: Novo Nordisk, Advisory Board/Consulting; Eli Lilly, Advisory Board/Consulting; Boehringer Ingelheim, Independent Contractor 

Ania Jastreboff, MD, PhD

Yale School of Medicine


Disclosures: Novo Nordisk, Faculty, Research Grant Support; Eli Lilly, Advisory Board/Consultant, Research Support; Intellihealth, Advisory Board/Consultant, obesity treatment platform; Boehringer Ingelheim, Consultant, stock options; Scholar Rock, Consultant; Pfizer, Consultant; American Diabetes Association, Advisory Board/Consultant; NIH/NIDDK, Research Support 

Scott Kahan, MD, MPH

National Center for Weight and Wellness


Disclosures: Novo Nordisk, consultant; Biologix, consultant; iNova Pharmaceuticals, consultant; Vivus, consultant; Amgen, consultant; Bausch, consultant 

Jonathan Purnell, MD

Oregon Health & Science University


Disclosures: Novo Nordisk, Advisor Global Obesity Program; Luciole Pharmaceuticals, Scientific Advisor 

Domenica Rubino, MD

Washington Center for Weight Management and Research


Disclosures: Novo Nordisk, Investigator (Institutional), Speaker, Consultant/Scientific Advisor, writing support; Boehringer Ingelheim,  Investigator (Institutional), Consultant, advisor; Epitomee Medical, Investigator (Institutional); Astra Zeneca, Investigator (Institutional); Eli Lilly,  consultant; Prime Therapeutics, speaker; Medscape/WebMD, speaker 

Taraneh Soleymani, MD

Hershey Medical Center


Disclosures: Novo Nordisk, Speakers Bureau

Amanda Velazquez,  MD



Disclosures: Weight Watchers, Advisory Board; Novo Nordisk, Consultant; Intellihealth, Advisory Board   

Michael Weintraub, MD

NYU Langone Health


Disclosures: None

Dimpi Desai (Expert Peer Reviewer)

Stanford University


Disclosures: None

This program was supported by an educational grant from Lilly and Novo Nordisk.

Have questions about the program? Contact

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By